NCT01034267

Brief Summary

The purpose of this study is to evaluate the long- term safety of F2695-SR in the treatment of adults with major depressive disorder.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
828

participants targeted

Target at P75+ for phase_3 major-depressive-disorder

Geographic Reach
1 country

68 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

December 16, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 17, 2009

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Last Updated

August 17, 2012

Status Verified

August 1, 2012

Enrollment Period

2.5 years

First QC Date

December 16, 2009

Last Update Submit

August 15, 2012

Conditions

Keywords

DepressionMajor Depressive Disorder

Outcome Measures

Primary Outcomes (1)

  • Adverse events, clinical laboratory tests, vital sign measurements, electrocardiograms, physical examinations, Columbia-Suicide Severity Rating Scale

    48 weeks

Study Arms (1)

1

EXPERIMENTAL

(Open-label) F2695 SR capsules, oral administration, once daily, flexible dosing

Drug: F2695 SR

Interventions

Drug F2695 SR (flexible dose) to be given orally in capsule form once daily

1

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Completed 1 of the lead-in studies LVM-MD-01, LVM-MD-02, or LVM-MD-03
  • Have normal examination findings at the final visit of the lead-in study
  • Have a negative serum pregnancy test at the final visit of the lead-in study if a woman of child-bearing potential

You may not qualify if:

  • Patients considered a suicide risk
  • Women who are pregnant, breastfeeding, or planning to become during the study OR are sexually active and not currently using a medically acceptable method of contraception

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (68)

Forest Investigative Site 55

Dothan, Alabama, 36305, United States

Location

Forest Investigative Site 29

Scottsdale, Arizona, 85254, United States

Location

Forest Investigative Site 31

Beverly Hills, California, 90210, United States

Location

Forest Investigative Site 3

Costa Mesa, California, 92626, United States

Location

Forest Investigative Site 12

Encino, California, 91316, United States

Location

Forest Investigative Site 6

Escondido, California, 92025, United States

Location

Forest Investigative Site 22

Oceanside, California, 92056, United States

Location

Forest Investigative Site 38

Sherman Oaks, California, 91403, United States

Location

Forest Investigative Site 36

Denver, Colorado, 80204, United States

Location

Forest Investigative Site 28

Denver, Colorado, 80239, United States

Location

Forest Investigative Site 65

Highlands Ranch, Colorado, 80130, United States

Location

Forest Investigative Site 30

Cromwell, Connecticut, 06416, United States

Location

Forest Investigative Site 57

Boca Raton, Florida, 33431, United States

Location

Forest Investigative Site 60

Boca Raton, Florida, 33432, United States

Location

Forest Investigative Site 18

Coral Springs, Florida, 33067, United States

Location

Forest Investigative Site 34

Fort Myers, Florida, 33912, United States

Location

Forest Investigative Site 64

Gainesville, Florida, 32607, United States

Location

Forest Investigative Site 45

Hallandale, Florida, 33009, United States

Location

Forest Investigative Site 17

Jacksonville, Florida, 32216, United States

Location

Forest Investigative Site 53

Ocala, Florida, 34471, United States

Location

Forest Investigative Site 13

Orlando, Florida, 32806, United States

Location

Forest Investigative Site 61

Orlando, Florida, 32806, United States

Location

Forest Investigative Site 27

West Palm Beach, Florida, 33407, United States

Location

Forest Investigative Site 59

Winter Park, Florida, 32789, United States

Location

Forest Investigative Site 70

Atlanta, Georgia, 30328, United States

Location

Forest Investigative Site 66

Smyrna, Georgia, 30080, United States

Location

Forest Investigative Site 33

Chicago, Illinois, 60634, United States

Location

Forest Investigative Site 23

Hoffman Estates, Illinois, 60169, United States

Location

Forest Investigative Site 50

Oak Brook, Illinois, 60523, United States

Location

Forest Investigative Site 63

Indianapolis, Indiana, 46260, United States

Location

Forest Investigative Site 71

Prairie Village, Kansas, 66206, United States

Location

Forest Investigative Site 5

Wichita, Kansas, 67206, United States

Location

Forest Investigative Site 52

Shreveport, Louisiana, 71104, United States

Location

Forest Investigative Site 1

Baltimore, Maryland, 21285, United States

Location

Forest Investigative Site 2

Glen Burnie, Maryland, 21061, United States

Location

Forest Investigative Site 37

Rockville, Maryland, 20852, United States

Location

Forest Investigative Site 32

Fall River, Massachusetts, 02721, United States

Location

Forest Investigative Site 15

East Lansing, Michigan, 48824, United States

Location

Forest Investigative Site 35

Cherry Hill, New Jersey, 08002, United States

Location

Forest Investigative Site 21

Willingboro, New Jersey, 08046, United States

Location

Forest Investigative Site 51

Brooklyn, New York, 11214, United States

Location

Forest Investigative Site 42

Brooklyn, New York, 11235, United States

Location

Forest Investigative Site 4

Mount Kisco, New York, 10549, United States

Location

Forest Investigative Site 16

New York, New York, 10003, United States

Location

Forest Investigative Site 39

New York, New York, 10021, United States

Location

Forest Investigative Site 9

Staten Island, New York, 10312, United States

Location

Forest Investigative Site 46

Raleigh, North Carolina, 27607, United States

Location

Forest Investigative Site 25

Canton, Ohio, 44718, United States

Location

Forest Investigative Site 10

Dayton, Ohio, 45408, United States

Location

Forest Investigative Site 56

Oklahoma City, Oklahoma, 73112, United States

Location

Forest Investigative Site 67

Oklahoma City, Oklahoma, 73112, United States

Location

Forest Investigative Site 40

Portland, Oregon, 97210, United States

Location

Forest Investigative Site 58

Salem, Oregon, 97301, United States

Location

Forest Investigative Site 54

Allentown, Pennsylvania, 18104, United States

Location

Forest Investigative Site 14

Media, Pennsylvania, 19063, United States

Location

Forest Investigative Site 43

Norristown, Pennsylvania, 19401, United States

Location

Forest Investigative Site 24

Philadelphia, Pennsylvania, 19107, United States

Location

Forest Investigative Site 44

Lincoln, Rhode Island, 02865, United States

Location

Forest Investigative Site 26

Memphis, Tennessee, 38119, United States

Location

Forest Investigative Site 20

Dallas, Texas, 75230, United States

Location

Forest Investigative Site 47

Dallas, Texas, 75231, United States

Location

Forest Investigative Site 62

San Antonio, Texas, 78229, United States

Location

Forest Investigative Site 7

San Antonio, Texas, 78229, United States

Location

Forest Investigative Site 8

Woodstock, Vermont, 05091, United States

Location

Forest Investigative Site 68

Virginia Beach, Virginia, 23452, United States

Location

Forest Investigative Site 19

Bellevue, Washington, 98007, United States

Location

Forest Investigative Site 41

Seattle, Washington, 98104, United States

Location

Forest Investigative Site 69

Spokane, Washington, 99204, United States

Location

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Giovana Forrero, MA

    Forest Research Institute, a subsidiary of Forest Laboratories Inc

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2009

First Posted

December 17, 2009

Study Start

December 1, 2009

Primary Completion

June 1, 2012

Last Updated

August 17, 2012

Record last verified: 2012-08

Locations